Selected research
Industry Growth & Trends
Global Blonanserin Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Blonanserin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Blonanserin Tablets include Intas, Lifecare Neuro Products, Recipharm, Sumitomo Pharma, Taj Life Sciences, LIVZON PHARMACEUTICAL, Shijiazhuang No.4 Pharmaceutical and Xiangzhong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Blonanserin Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Blonanserin Tablets market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blonanserin Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blonanserin Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Blonanserin Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Blonanserin Tablets Market by Company
Intas
Lifecare Neuro Products
Recipharm
Sumitomo Pharma
Taj Life Sciences
LIVZON PHARMACEUTICAL
Shijiazhuang No.4 Pharmaceutical
Xiangzhong Pharmaceutical
Blonanserin Tablets Segment by Type
4mg
8mg
Blonanserin Tablets Segment by Application
Adults
Children
Blonanserin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blonanserin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blonanserin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blonanserin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blonanserin Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Blonanserin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 4mg
- 8mg
Applications
- Adults
- Children
Companies covered
- Intas
- Lifecare Neuro Products
- Recipharm
- Sumitomo Pharma
- Taj Life Sciences
- LIVZON PHARMACEUTICAL
- Shijiazhuang No.4 Pharmaceutical
- Xiangzhong Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Blonanserin Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Blonanserin Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Blonanserin Tablets Market by Type
- 1.3.1 4mg
- 1.3.2 8mg
- 1.4 Global Blonanserin Tablets Market Size by Type
- 1.4.1 Global Blonanserin Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Blonanserin Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Blonanserin Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Blonanserin Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Blonanserin Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Blonanserin Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Blonanserin Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Blonanserin Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Blonanserin Tablets Industry Trends
- 2.2 Blonanserin Tablets Industry Drivers
- 2.3 Blonanserin Tablets Industry Opportunities and Challenges
- 2.4 Blonanserin Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Blonanserin Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Blonanserin Tablets Sales (2021-2026)
- 3.3 Global Top Players by Blonanserin Tablets Price (2021-2026)
- 3.4 Global Blonanserin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Blonanserin Tablets Major Company Production Sites & Headquarters
- 3.6 Global Blonanserin Tablets Company, Product Type & Application
- 3.7 Global Blonanserin Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Blonanserin Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Blonanserin Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Blonanserin Tablets Tier 1, Tier 2, and Tier 3
4 Blonanserin Tablets Regional Status and Outlook
- 4.1 Global Blonanserin Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Blonanserin Tablets Historic Market Size by Region
- 4.2.1 Global Blonanserin Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Blonanserin Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Blonanserin Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Blonanserin Tablets Forecasted Market Size by Region
- 4.3.1 Global Blonanserin Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Blonanserin Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Blonanserin Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blonanserin Tablets by Application
- 5.1 Blonanserin Tablets Market by Application
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Blonanserin Tablets Market Size by Application
- 5.2.1 Global Blonanserin Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Blonanserin Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Blonanserin Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Blonanserin Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Blonanserin Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Blonanserin Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Blonanserin Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Blonanserin Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Intas
- 6.1.1 Intas Company Information
- 6.1.2 Intas Business Overview
- 6.1.3 Intas Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Intas Blonanserin Tablets Product Portfolio
- 6.1.5 Intas Recent Developments
- 6.2 Lifecare Neuro Products
- 6.2.1 Lifecare Neuro Products Company Information
- 6.2.2 Lifecare Neuro Products Business Overview
- 6.2.3 Lifecare Neuro Products Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Lifecare Neuro Products Blonanserin Tablets Product Portfolio
- 6.2.5 Lifecare Neuro Products Recent Developments
- 6.3 Recipharm
- 6.3.1 Recipharm Company Information
- 6.3.2 Recipharm Business Overview
- 6.3.3 Recipharm Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Recipharm Blonanserin Tablets Product Portfolio
- 6.3.5 Recipharm Recent Developments
- 6.4 Sumitomo Pharma
- 6.4.1 Sumitomo Pharma Company Information
- 6.4.2 Sumitomo Pharma Business Overview
- 6.4.3 Sumitomo Pharma Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sumitomo Pharma Blonanserin Tablets Product Portfolio
- 6.4.5 Sumitomo Pharma Recent Developments
- 6.5 Taj Life Sciences
- 6.5.1 Taj Life Sciences Company Information
- 6.5.2 Taj Life Sciences Business Overview
- 6.5.3 Taj Life Sciences Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taj Life Sciences Blonanserin Tablets Product Portfolio
- 6.5.5 Taj Life Sciences Recent Developments
- 6.6 LIVZON PHARMACEUTICAL
- 6.6.1 LIVZON PHARMACEUTICAL Company Information
- 6.6.2 LIVZON PHARMACEUTICAL Business Overview
- 6.6.3 LIVZON PHARMACEUTICAL Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 LIVZON PHARMACEUTICAL Blonanserin Tablets Product Portfolio
- 6.6.5 LIVZON PHARMACEUTICAL Recent Developments
- 6.7 Shijiazhuang No.4 Pharmaceutical
- 6.7.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 6.7.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 6.7.3 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Product Portfolio
- 6.7.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 6.8 Xiangzhong Pharmaceutical
- 6.8.1 Xiangzhong Pharmaceutical Company Information
- 6.8.2 Xiangzhong Pharmaceutical Business Overview
- 6.8.3 Xiangzhong Pharmaceutical Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Xiangzhong Pharmaceutical Blonanserin Tablets Product Portfolio
- 6.8.5 Xiangzhong Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Blonanserin Tablets Sales by Country
- 7.1.1 North America Blonanserin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Blonanserin Tablets Sales by Country (2021-2026)
- 7.1.3 North America Blonanserin Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Blonanserin Tablets Market Size by Country
- 7.2.1 North America Blonanserin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Blonanserin Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Blonanserin Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Blonanserin Tablets Sales by Country
- 8.1.1 Europe Blonanserin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Blonanserin Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Blonanserin Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Blonanserin Tablets Market Size by Country
- 8.2.1 Europe Blonanserin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Blonanserin Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Blonanserin Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Blonanserin Tablets Sales by Country
- 9.1.1 Asia-Pacific Blonanserin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Blonanserin Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Blonanserin Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Blonanserin Tablets Market Size by Country
- 9.2.1 Asia-Pacific Blonanserin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Blonanserin Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Blonanserin Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Blonanserin Tablets Sales by Country
- 10.1.1 South America Blonanserin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Blonanserin Tablets Sales by Country (2021-2026)
- 10.1.3 South America Blonanserin Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Blonanserin Tablets Market Size by Country
- 10.2.1 South America Blonanserin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Blonanserin Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Blonanserin Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Blonanserin Tablets Sales by Country
- 11.1.1 Middle East and Africa Blonanserin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Blonanserin Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Blonanserin Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Blonanserin Tablets Market Size by Country
- 11.2.1 Middle East and Africa Blonanserin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Blonanserin Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Blonanserin Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Blonanserin Tablets Value Chain Analysis
- 12.1.1 Blonanserin Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Blonanserin Tablets Production Mode & Process
- 12.2 Blonanserin Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Blonanserin Tablets Distributors
- 12.2.3 Blonanserin Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst